Plus Vitech SL (PVT)is a newly created innovative SME, which focuses on the development and validation of a new strategy for diagnosis and treatments in cancer.
The cancer is the epidemic of the XXI century. 1 of 3 people will suffer from cancer. With the current treatments, only 40% will survive. Cancer is a very elusive illness: Each type is different and evolves in every person over time.
Our technology is based on a specific protein receptor of the tumor cells. That protein plays an important role in cancer´s cells survival and progression. Furthermore, it is different in tumor and normal cells. These properties offer an opportunity to develop a highly effective and specific cancer treatment and develop a robust diagnostic method.